JOSHUA BOGER ’73, chairman and chief executive officer of Vertex Pharmaceuticals, was recently named as one of 40 Technology Pioneers by the World Economic Forum. Selected for their company’s innovative approach, potential impact, growth and sustainability, proof of concept and leadership, these individuals traveled to Switzerland to participate with other business leaders in the forum. Vertex Pharmaceuticals, a biotechnology corporation, applies an integrated, multi-disciplinary approach to discover, develop and commercialize drugs. In the last three years alone, Vertex has used its proprietary drug discovery capability to advance 12 new drugs into development with the potential to treat debilitating and life-threatening diseases. Boger, a trustee of Wesleyan, received both his master’s and doctoral degrees from Harvard University.
